glp-1 news today 2025 november 5 ISPOR 2025: Exploring reasons for discontinuation Discounted GLP-1 Weight Loss Drugs

Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of kidney outcomes: emulation of a target trial using health care databases

Emerging evidence suggests that metabolic syndrome in transplant recipients is associated with fibrosis development

Liraglutide for metabolic effects Three GLP-1 agonists are FDA approved for the treatment of obesity

The real power comes from combining multiple approaches synergistically

8 The following algorithm has been proposed for the management of patients taking GLP-1-RA presenting for surgery (Figure 2)

Remedy Meds Focuses exclusively on GLP-1 medications and has clear, transparent pricing